Summary: Germline heterozygous PTEN mutations are associated with tissue overgrowth, autism spectrum disorder and increased cancer risk; this study presents a mouse model representing recurrent human PTEN variants, to elucidate disease outcomes. This evidence concerns the gene PTEN and autism spectrum disorder.